Morgan Stanley
-
Hony Capital has raked in a whopping HK$11.1bn ($1.43bn) by exiting CSPC Pharmaceutical and Chinasoft International via two block trades that hit the market in quick succession, ending the PE firm’s involvement in these Hong Kong-listed companies. -
Bahrain’s Ahli United Bank has launched $400m of additional tier one notes at a yield of 6.875%, well inside the trading of comparable issuer Burgan Bank’s perpetuals though the deal is $100m smaller.
-
China Zhongdi Dairy Holdings Co has filed a listing application with the Hong Kong Stock Exchange via sole sponsor Morgan Stanley.
-
Bahrain’s Ahli United Bank has released price guidance for its perpetual tier one bond at low 7% area. A syndicate official away from the deal called the guidance fair and said the deal would act as a test of Middle East liquidity after the fall in the oil price.
-
Doosan Heavy Industries & Construction has made a solid entry into the US dollar bond market, raising $500m from a deal that came backed by Export-Import Bank of Korea (Kexim). The transaction’s success and jubilant investor response bodes well for the wider market, opening up opportunities for other issuers to raise offshore debt with guarantees from policy banks.
-
Morgan Stanley has delivered its best quarterly figures since the onset of the financial crisis, driven by strong equities and fixed income performance.
-
A FIG DCM banker at Goldman Sachs has left to take on a similar job at US rival Morgan Stanley.
-
Investors piled into Southern Copper’s 10 and 30 year bonds on Monday in what a banker on the deal said was only the second new issue from a metals and mining credit in any markets so far this year.
-
Doosan Heavy Industries & Construction has opened books for its first dollar bond in the offshore market on Monday, having completed a global roadshow last week.
-
E-commerce based Baozun Inc is seeking an IPO on the Nasdaq to raise $200m, in what will be the first US listing of a Chinese technology firm exceeding $100m since December 2014.
-
Hony Capital has made a full exit from CSPC Pharmaceutical Group after having gradually trimmed its stake over the past two years, taking advantage of the recent rally in the Hong Kong index to net a whopping HK$9.78bn ($1.26bn) on April 16.
-
